Cargando…
Risk of Cardiovascular Events in Patients With Diabetes Mellitus on β-Blockers
Although the use of β-blockers may help in achieving maximum effects of intensive glycemic control because of a decrease in the adverse effects after severe hypoglycemia, they pose a potential risk for the occurrence of severe hypoglycemia. This study aimed to evaluate whether the use of β-blockers...
Autores principales: | Tsujimoto, Tetsuro, Sugiyama, Takehiro, Shapiro, Martin F., Noda, Mitsuhiko, Kajio, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott, Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739105/ https://www.ncbi.nlm.nih.gov/pubmed/28559400 http://dx.doi.org/10.1161/HYPERTENSIONAHA.117.09259 |
Ejemplares similares
-
Effects of β‐blockers on all‐cause mortality in patients with type 2 diabetes and coronary heart disease
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017) -
Beta-blocker use and cardiovascular event risk in patients with heart failure with preserved ejection fraction
por: Tsujimoto, Tetsuro, et al.
Publicado: (2018) -
Favourable changes in mortality in people with diabetes: US NHANES 1999–2010
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017) -
Obesity, diabetes, and length of time in the United States: Analysis of National Health and Nutrition Examination Survey 1999 to 2012
por: Tsujimoto, Tetsuro, et al.
Publicado: (2016) -
Thiazide Use and Cardiovascular Events in Type 2 Diabetic Patients With Well-Controlled Blood Pressure
por: Tsujimoto, Tetsuro, et al.
Publicado: (2019)